Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) POSTED

Grants.gov opportunity · National Institutes of Health · view on grants.gov ↗

Key facts

Opportunity ID: 357202
Opportunity number: PAR-25-069
Agency: National Institutes of Health
Status: posted
Document type: synopsis
Open date: 11/18/2024
Close date: 01/07/2027
CFDA codes: 93.393